CD73 inhibition overcomes adaptive immune resistance to PARP inhibiton in models of prostate cancer. (jci.org)

Authors: Xie P … Zhang B Journal: Journal of Clinical Investigation Published: 2026-08-18 DOI: https://doi.org/10.1172/JCI203785